ChemPartner Blog

By: Dr. Jie Jack Li, Vice President of Discovery Chemistry at ChemPartner On June 16th, 2020, a team at Oxford University announced that their RECOVERY trials had revealed that a daily treatment of 6 mg of dexamethasone (Decadron, 1) lowered the fatality rate of ventilated COVID-19 patients by up to...
Read More

By: Dr. Jie Jack Li, Vice President of Discovery Chemistry at ChemPartner Gileadʹs antiviral drug remdesivir (Veklury, 1) was approved by the FDA on May 1st for emergency use against coronavirus disease-2019 (COVID-19) after just a one-day review. Now the onerous task falls upon Gilead to make enoug...
Read More

By: Dr. Jie Jack Li, Vice President of Discovery Chemistry at ChemPartner Gileadʹs antiviral drug remdesivir (Veklury) was approved by the FDA on May 1, 2020 for emergency use in coronavirus disease-2019 (COVID-19) patients after a one-day review. It took the Japanese government much longer to give ...
Read More

By: Dr. Jie Jack Li, Vice President of Discovery Chemistry at ChemPartner Gileadʹs antiviral drug remdesivir has been catapulted to the limelight as the only FDA-approved treatment of coronavirus Covid-19 for emergency use thus far. On April 29, 2020, preliminary clinical trials indicated that the d...
Read More

By: Dr. Manny Ventura, Director and Global Head of Analytical Chemistry at ChemPartner Supercritical fluid chromatography (SFC) is now a well-established tool incorporated into the small molecule drug development strategy for organizations of all types and sizes. Its imprint is almost surely on the ...
Read More

By: Dr. Kevin Greenman, Principal Scientist at ChemPartner When it comes to finding new chemical matter to engage biological targets, fragment-based screening (FBS) offers a number of advantages over traditional high-throughput screening (HTS). The success of this approach has resulted in a growing ...
Read More

By: Dr. Shireen Khan, Senior Director of Biologics at ChemPartner Through our partnership with single cell technology company Berkeley Lights, Inc., ChemPartner offers the innovative Optofluidic based Beacon® platform at our South San Francisco lab. The nano chip technology of the  Beacon® platform ...
Read More